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Rickettsiae are Gram-negative alpha proteobacte-
ria and arthropod-borne disease agents of spotted
fevers and typhus [1]. Because of their obligate
intracellular lifestyle, the molecular mechanisms
involved in their pathogenicity are still poorly
understood. To circumvent the difﬁculties in
working with these bacteria, rickettsial genomes
have been sequenced, thus allowing further post-
genomic studies.
DNA microarrays can be considered as power-
ful tools to understand the host–pathogen inter-
actions in the course of infectious diseases.
Exploring the RNA proﬁles of both host and
pathogen promises to improve our knowledge of
the infectious process, thus favouring the devel-
opment of preventive or therapeutic strategies [2].
While published studies mainly focused on the
eukaryotic response, the complementary picture,
i.e. the bacterial response, was poorly analysed
because of several technical limitations [3].
The transcriptomic analysis of R. conorii was
recently performed by microarrays [4]. This bac-
terium is responsible for Mediterranean spotted
fever (MSF), a disease characterised by a skin
lesion called eschar caused by the bite of its
vector, the brown dog tick, Rhipicephalus sanguin-
eus [5]. The aim of this work was to analyse the
transcriptome pattern of rickettsiae within such
eschars using the same strategy based on the
removal of eukaryotic contaminants coupled with
subsequent random ampliﬁcation of cDNA. Our
goal was also to recover eukaryotic RNA from the
same sample, thus considering both sides of the
host–pathogen interaction.
Preliminary assays were performed using
rabbit eschars generated by the sub-cutaneous
inoculation of puriﬁed bacteria (not shown).
Human eschars were collected by sterile scalpel
excision from patients suffering from MSF and
immediately placed at 4C overnight in 1 mL of
RNA Later (Qiagen, Valencia, California, USA)
before storage at )80C. The biopsies were rap-
idly decontaminated by a 5-min incubation in
iodated alcohol and 1 min washing in nuclease
free water. The tissues excised in small pieces
were mechanically lysed with tungsten beads and
using the Mixer Mill MM3 (Qiagen), before
enzymatic digestion with proteinase K. The total
RNA was extracted from resulting lysates using
the RNeasy Micro kit (Qiagen). Eukaryotic RNA
was removed from the total RNA sample using
the MicroEnrich Kit (Ambion, Austin, Texas,
USA) as described [4]. To recover the eukaryotic
RNA from the same sample, the beads were then
mixed in TE buffer pH 8 and heated for 1 min at
95C. The supernatants were collected and pre-
cipitated with alcohol. The bacterial RNA was
retro-transcribed using random primers and
ampliﬁed with the Genomiphi kit (GE Healthcare,
Piscataway, New Jersey, USA), while human
RNA was ampliﬁed using poly d(T) primers with
T7 polymerase (Agilent, Santa Clara, California,
USA). To check for the quality of ampliﬁcation,
PCR were performed on cDNA using primers
targeting the rrs gene from R. conorii (F- GGCT-
CAGAACGAACGCTATC ⁄R-GTTAGCTGCGAA-
ACCGAAAG) and the eukaryotic actin gene
(F-GGACTTCGAGCAAGAGATGG ⁄R-AGCACT-
GTGTTGGCGTACAG), respectively. Hybridisa-
tions of prokaryotic cDNA were achieved
following Cy3 or Cy5 labelling of R. conorii from
eschars and using bacteria grown in vero cells as
control. R. conorii microarrays were obtained
from Agilent (‘Custom microarray’ design) and
processed as described [6]. Hybridisations of
human microarrays (Agilent) were performed
with one colour labelling as recommended.
The electrophoregrams obtained with the Bio-
analyzer (Agilent) indicated that the extraction of
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infected tissue preserved the integrity of the total
RNA (Fig. 1a). Our protocol yielded around
500 ng of total RNA starting from 1 mg of
infected eschars. Following the subtractive
hybridisation approach, around 50 ng of puriﬁed
prokaryotic RNA per mg of infected tissues were
obtained. Up to 90% of the eukaryotic RNA
retained onto beads was recovered while some
degradation was likely to occur (Fig. 1a). The
puriﬁcation of both fractions was conﬁrmed by
RT-PCR. Thus, we successfully ampliﬁed b-actin
(eukaryotic target) and rrs (prokaryotic target)
from the initial sample of total RNA. In contrast,
the puriﬁed prokaryotic fraction was found to be
devoid of eukaryotic contaminants, while the
RNA eluted from beads gave only a positive
signal when using primers targeting actin gene
(Fig. 1b). Using such a sample, reproducible
patterns of microarray hybridisation were ob-
tained. The M-A plots showed that the signals of
labelled targets exhibited homogenous distribu-
tion (Fig. 1c).
This approach has great potential to study the
whole picture of host–pathogen interactions by
microarrays.
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Fig. 1. Transcriptomic proﬁles of host-pathogens. (a) Elec-
trophoregrams of RNA. (b) RT-PCR ampliﬁcation using
primers targeting b-actin or rrs. T (total RNA), Rco
(puriﬁed R. conorii), H (human RNA recovered from
beads). (c) M-A plot of biological replicates of R. conorii
and human microarrays.
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